Latest Stock Buy or Sell? Make More Informed Decisions!

Stockchase Research Editor: Michael O'Reilly We reiterate BMY, a $139 billion marketcap pharma player, as a TOP PICK. The recent $13 billion acquisition of a company that focuses on blood cancer treatment has gone well, but analysts have held the stock value back as the drug will lose patent protection in 2023. If you believe in the strength of management this will not be a game changer. Recent reported earnings beat market expectations by 4% and its ROE is over 40%. It pays a good dividend that has grown over 40% over the past three years. We would continue to use $54 as a stop-loss, looking to achieve $72.50 -- over 16% upside. Yield 3.19% (Analysts’ price target is $72.50)

Stockchase Research Editor: Michael O'Reilly This maker of industrial optic and laser components, is once again reiterated as a TOP PICK. The company remains well positioned to benefit from 5G rollout, cloud migration, and EVs. We like that it has continued to increase cash reserves, while reducing debt. It trades at 15x expected next year earnings compared to peers at 23x. We recommend trailing up the stop to $58.50, looking to achieve $91 -- upside potential over 27%. Yield 0% (Analysts’ price target is $90.62)

Stockchase Research Editor: Michael O'Reilly This Canadian based financial service provider, with $43 billion under management, is reiterated as a TOP PICK. It has diversified out to include alternative investment products -- bespoke investment beyond traditional stocks and bonds. It trades at only 4x earnings compared to peers at 9x, is trading below book value, and has no long term debt. It pays a good dividend, backed by a payout ratio of under 55% of cash flow. We recommend trailing up the stop to $6.50, looking to achieve $9.75 -- over 16% upside. Yield 4.45%

Stockchase research editor Michael O'Reilly reiterated it as a top pick twice this December. Jim Cramer and Darren Sissons both recently gave positive signals. Social media mentions are down 30% over the past 7 days but it remains in the top 10 most discussed stocks.

Up since October. Strong demand for chips. Stockchase research editor Michael O'Reilly and Kim Bolton both recently selected it as a top pick. Social media mentions are up 2000% over the last 7 days.

Still profiting from huge investments in infrastructure. Jim Cramer recently gave a BUY signal. Social media mentions are up 300% over the past 24h.